Showing 5431-5440 of 20465 results for "".
- Evolving Cardiovascular Risks: Addressing Today's Clinical Challengeshttps://reachmd.com/news/evolving-cardiovascular-risks-addressing-todays-clinical-challenges/2483547/The landscape of cardiovascular risks is shifting significantly, presenting both challenges and opportunities for innovation in public health. In the U.S., based on national surveillance estimates from recent years, about
- Pediatric Septic Shock Management: The Role of Hemodynamic Ultrasoundhttps://reachmd.com/news/revolutionizing-pediatric-shock-management-the-role-of-hemodynamic-ultrasound/2483543/In pediatric critical care, hemodynamic point-of-care ultrasound (POCUS)—also termed functional echocardiography—stands out as a valuable adjunct, helping refine timely interventions and support clinical decision-making within pediatric septic shock care, while guidelines position it as a c
- Ocrelizumab: Leading the Charge in MS Relapse Managementhttps://reachmd.com/news/ocrelizumab-leading-the-charge-in-ms-relapse-management/2483527/In the dynamic landscape of multiple sclerosis (MS), managing relapses represents an ever-present challenge, as reflected in major society recommendations for disease-modifying therapy in relapsing forms of MS. Ocrelizumab is carving out its place as a pivotal player in this arena, promisin
- The Role of Gut Microbiota in Sickle Cell Disease-Related Painhttps://reachmd.com/news/the-role-of-gut-microbiota-in-sickle-cell-disease-related-pain/2483523/Chronic pain is straining pediatric sickle cell care, while the gut microbiome is emerging as a possible contributor—an ongoing puzzle linking inflammation and pain. The gut–immune axis may help explain why some children with sickle cell disease (SCD) experience ampl
- Tezepelumab: A Transformative Approach in Severe Asthma Managementhttps://reachmd.com/news/tezepelumab-a-transformative-approach-in-severe-asthma-management/2483533/In the rapidly advancing world of asthma treatment, tezepelumab stands out as an important addition for severe cases. It is FDA-approved as add-on maintenance for severe asthma, and guidelines position it as an option after high-dose ICS/LABA in patients with ongoing exacerbations, regardle
- Colistin Resistance in Healthcare: Mechanisms and Managementhttps://reachmd.com/news/colistin-resistance-in-healthcare-mechanisms-and-management/2483530/In the battle against multidrug-resistant bacteria, colistin has emerged as a critical last-resort antibiotic. However, the rising tide of colistin resistance poses a significant threat to its efficacy, necessitating an urgent understanding of the underlying mechanisms and their clinical im
- Harnessing AI for Early Asthma Risk Prediction in Children: A New Frontier in Pediatric Carehttps://reachmd.com/news/harnessing-ai-for-early-asthma-risk-prediction-in-children-a-new-frontier-in-pediatric-care/2483524/Asthma in children poses a significant challenge to clinicians worldwide. Traditional methods of predicting asthma risks are being revolutionized by artificial intelligence (AI), unlocking new possibilities for personalized pediatric care while also surfacing the central tension: prediction
- Uncorking the Truth: Reevaluating Alcohol Consumption and Dementia Riskhttps://reachmd.com/news/uncorking-the-truth-reevaluating-alcohol-consumption-and-dementia-risk/2483531/Can a single drink quietly tip the scales toward dementia? As new research is surfacing, the potential risks of even moderate alcohol consumption on cognitive health are coming into sharper focus, challenging traditional wisdom. While risk may increase even at low levels, public health guid
- The Role of EML4-ALK Variants in Lung Cancer Aggressiveness and Treatmenthttps://reachmd.com/news/the-role-of-eml4-alk-variants-in-lung-cancer-aggressiveness-and-treatment/2483535/A subset of lung adenocarcinomas is driven by the complex EML4-ALK gene fusion, continuously challenging oncologists and reflecting the dynamic landscape of genetic influence on cancer aggressiveness. The same genetic fusion that accelerates cancer progression in lun
- Unveiling the Connection: Retinal Vein Occlusion and Stroke Riskhttps://reachmd.com/news/unveiling-the-connection-retinal-vein-occlusion-and-stroke-risk/2483506/Retinal vein occlusion (RVO), long recognized as a leading cause of vision loss in older adults, may carry far more systemic significance than previously appreciated. Beyond its ophthalmic manifestations, RVO is now emerging as a potent predictor of cerebrovascular